Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1965 1
1973 1
1976 2
1977 1
1981 1
1982 1
1984 2
1985 4
1986 2
1987 5
1988 3
1989 2
1990 2
1991 2
1992 1
1993 5
1994 2
1995 6
1996 5
1997 5
1998 5
1999 3
2000 4
2001 3
2002 5
2003 12
2004 31
2005 31
2006 29
2007 28
2008 24
2009 22
2010 17
2011 14
2012 20
2013 22
2014 34
2015 35
2016 43
2017 46
2018 48
2019 63
2020 1448
2021 9979
2022 6154
Text availability
Article attribute
Article type
Publication date

Search Results

16,427 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: vaccine
Page 1
Acceptance of the COVID-19 vaccine based on the health belief model: a multicenter national survey among medical care workers in China.
Wang H, Huang YM, Su XY, Xiao WJ, Si MY, Wang WJ, Gu XF, Ma L, Li L, Zhang SK, Yang CX, Yu YQ, Qiao YL. Wang H, et al. Hum Vaccin Immunother. 2022 May 18:2076523. doi: 10.1080/21645515.2022.2076523. Online ahead of print. Hum Vaccin Immunother. 2022. PMID: 35583502
Vaccine uptake rate is crucial for herd immunity. Medical care workers (MCWs) can serve as ambassadors of COVID-19 vaccine acceptance. This study aimed to assess MCWs' willingness to receive the COVID-19 vaccine, and to explore the factors affecting …
Vaccine uptake rate is crucial for herd immunity. Medical care workers (MCWs) can serve as ambassadors of COVID-19 vaccine acc …
Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
Kashiwada T, Saito Y, Terasaki Y, Shirakura Y, Shinbu K, Tanaka T, Tanaka Y, Seike M, Gemma A. Kashiwada T, et al. Hum Vaccin Immunother. 2022 May 18:2071080. doi: 10.1080/21645515.2022.2071080. Online ahead of print. Hum Vaccin Immunother. 2022. PMID: 35583472
We report here a case of Kikuchi-Fujimoto disease, which occurred three months after vaccination with COVID-19 vaccine. ...It implies the possibility of Kikuchi-Fujimoto Disease in axillary drainage lymph nodes in association with COVID-19
We report here a case of Kikuchi-Fujimoto disease, which occurred three months after vaccination with COVID-19 vaccine. …
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments.
Mahmud N, Anik MI, Hossain MK, Khan MI, Uddin S, Ashrafuzzaman M, Rahaman MM. Mahmud N, et al. ACS Appl Bio Mater. 2022 May 18. doi: 10.1021/acsabm.2c00123. Online ahead of print. ACS Appl Bio Mater. 2022. PMID: 35583460 Review.
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently developed variants of the SARS-CoV-2 vi
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that emerged less t …
Pfizer-BioNTech COVID-19 vaccine associated tinnitus and treatment with transcranial magnetic stimulation.
Chen JJ, Zeng BY, Lui CC, Chen TY, Chen YW, Tseng PT. Chen JJ, et al. QJM. 2022 May 18:hcac124. doi: 10.1093/qjmed/hcac124. Online ahead of print. QJM. 2022. PMID: 35583323
The COVID-19 vaccine associated tinnitus had become well recognized after its development and widely usage. ...The current report provided a point of view that the anti-inflammatory effect by rTMS might be considered to be an alternative choice to manage COVID
The COVID-19 vaccine associated tinnitus had become well recognized after its development and widely usage. ...The current rep …
Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease.
Duong TA, Bryant RV, Andrews JM, Lynch KD. Duong TA, et al. Intern Med J. 2022 May 18. doi: 10.1111/imj.15722. Online ahead of print. Intern Med J. 2022. PMID: 35583312
The majority of the Australian public are willing to have a Coronavirus disease 2019 (COVID-19) vaccination. It is unclear whether people with inflammatory bowel disease (IBD) have the same attitude towards COVID-19 vaccinat …
The majority of the Australian public are willing to have a Coronavirus disease 2019 (COVID-19) vaccinati …
Dynamic Planning of a Two-Dose Vaccination Campaign with Uncertain Supplies.
Calafiore G, Parino F, Zino L, Rizzo A. Calafiore G, et al. Eur J Oper Res. 2022 May 13. doi: 10.1016/j.ejor.2022.05.009. Online ahead of print. Eur J Oper Res. 2022. PMID: 35582705 Free PMC article.
The ongoing COVID-19 pandemic has led public health authorities to face the unprecedented challenge of planning a global vaccination campaign, which for most protocols entails the administration of two doses, separated by a bounded but flexible time interval. ...We …
The ongoing COVID-19 pandemic has led public health authorities to face the unprecedented challenge of planning a global vacci …
Relationship between blood clots and COVID-19 vaccines: A literature review.
Atyabi SMH, Rommasi F, Ramezani MH, Ghane Ezabadi MF, Arani MA, Sadeghi MH, Ahmed MM, Rajabi A, Dehghan N, Sohrabi A, Seifi M, Nasiri MJ. Atyabi SMH, et al. Open Life Sci. 2022 Apr 26;17(1):401-415. doi: 10.1515/biol-2022-0035. eCollection 2022. Open Life Sci. 2022. PMID: 35582622 Free PMC article. Review.
SARS-CoV-2 pandemic is one of the most critical pandemics during human civilization. Several therapeutic strategies for COVID-19 management have been offered; nonetheless, none of them seems to be sufficiently beneficial. ...
SARS-CoV-2 pandemic is one of the most critical pandemics during human civilization. Several therapeutic strategies for
Comparison of COVID-19 Inactivated Virus Vaccine Immunogenicity Between Healthy Individuals and Patients on Hemodialysis: A Single-Center Study From Pakistan.
Bai S, Dhrolia M, Qureshi H, Qureshi R, Nasir K, Ahmad A. Bai S, et al. Cureus. 2022 Apr 15;14(4):e24153. doi: 10.7759/cureus.24153. eCollection 2022 Apr. Cureus. 2022. PMID: 35582560 Free PMC article.
Introduction This study compares the immune response after coronavirus disease 2019 (COVID-19) inactivated virus vaccine between healthy individuals (HI) and patients on hemodialysis (HD). ...No HD patient developed COVID-19
Introduction This study compares the immune response after coronavirus disease 2019 (COVID-19) inactivate …
Humoral response to heterologous SARS-CoV-2 vaccination in kidney transplant patients is heterogeneous and dose-dependent.
Seija M, Rammauro F, Noboa J, Santiago J, Orihuela N, Zulberti C, Machado D, Recalde C, Astesiano R, Yandián F, Frantchez V, Guerisoli A, Morra A, Cassinelli D, Coelho C, de Aramburu B, González-Severgnini P, Moreno R, Pippolo A, López G, Lemos M, Somariva L, López E, Fumero S, Orihuela C, Suarez AL, Rodríguez R, Acuña G, Rabaza V, Perg N, Cordero R, Reisfeld C, Olivera P, Montero P, Nogueira C, Nalerio C, Orihuela S, Curi L, Bugstaller E, Pritsch O, Nin M, Noboa O, Bianchi S. Seija M, et al. Kidney Int Rep. 2022 May 13. doi: 10.1016/j.ekir.2022.05.005. Online ahead of print. Kidney Int Rep. 2022. PMID: 35582205 Free PMC article. No abstract available.
Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial.
Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, McHarry K, van den Hoogen G, Muller C, von Delft A, van der Westhuizen HM, van Crevel R, Walzl G, Baptista PM, Peter J, Diacon AH; BCG CORONA Consortium. Upton CM, et al. EClinicalMedicine. 2022 Jun;48:101414. doi: 10.1016/j.eclinm.2022.101414. Epub 2022 May 12. EClinicalMedicine. 2022. PMID: 35582122 Free PMC article.
Similarly, BCG had no statistically significant effect on COVID-19 (p = 0.63, HR = 1.08, 95% CI 0.82-1.42). Two participants (0.2%) died from COVID-19 and two (0.2%) from other reasons, all in the placebo group. INTERPRETATION: BCG did no …
Similarly, BCG had no statistically significant effect on COVID-19 (p = 0.63, HR = 1.08, 95% CI 0.82-1.42). Two participants ( …
Concomitant myocarditis and painless thyroiditis after AstraZeneca coronavirus disease 2019 vaccination: a case report.
Marsukjai A, Theerasuwipakorn N, Tumkosit M, Chattranukulchai P, Srichomkwun P, Prechawat S. Marsukjai A, et al. J Med Case Rep. 2022 May 17;16(1):212. doi: 10.1186/s13256-022-03438-z. J Med Case Rep. 2022. PMID: 35581666
BACKGROUND: Incidence of myocarditis following messenger RNA coronavirus disease 2019 vaccination has been widely described, but this clinical scenario after adenoviral vector coronavirus disease 2019 vaccination has only been rarely repo …
BACKGROUND: Incidence of myocarditis following messenger RNA coronavirus disease 2019 vaccination has been widely descr …
The assistance gaps in combating COVID-19 in Brazil: for whom, where and when vaccination occurs.
Moreira RDS, Costa EG, Dos Santos LFR, Miranda LHL, de Oliveira RR, Romão RF, Cozer RF, Guedes SC. Moreira RDS, et al. BMC Infect Dis. 2022 May 17;22(1):473. doi: 10.1186/s12879-022-07449-5. BMC Infect Dis. 2022. PMID: 35581560
BACKGROUND: Following the emergence of the COVID-19 pandemic, the number of infected Brazilian people has increased dramatically since February 2020, with Brazil being amongst the countries with the highest number of cases and deaths. ...METHODS: Spatial and tempora …
BACKGROUND: Following the emergence of the COVID-19 pandemic, the number of infected Brazilian people has increased dramatical …
Flu vaccine could cut COVID risk.
Callaway E. Callaway E. Nature. 2022 May 16. doi: 10.1038/d41586-022-01315-9. Online ahead of print. Nature. 2022. PMID: 35581411 No abstract available.
Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021.
Teasdale CA, Ratzan S, Stuart Lathan H, Rauh L, Kimball S, El-Mohandes A. Teasdale CA, et al. Vaccine. 2022 May 11:S0264-410X(22)00580-1. doi: 10.1016/j.vaccine.2022.05.010. Online ahead of print. Vaccine. 2022. PMID: 35581098
School-based vaccine mandates improve vaccination coverage in children. We conducted a cross-sectional survey of parents in New York City (NYC) in November 2021 to measure acceptability of COVID-19 vaccine mandates for students, and for teachers and school st …
School-based vaccine mandates improve vaccination coverage in children. We conducted a cross-sectional survey of parents in New York …
Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
Tenforde MW, Self WH, Zhu Y, Naioti EA, Gaglani M, Ginde AA, Jensen K, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Ten Lohuis C, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Exline MC, Botros MM, Lauring AS, Shapiro NI, Halasa N, Chappell JD, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Lindsell CJ, Hart KW, Turbyfill C, Olson S, Murray N, Adams K, Patel MM; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Tenforde MW, et al. Clin Infect Dis. 2022 May 17:ciac381. doi: 10.1093/cid/ciac381. Online ahead of print. Clin Infect Dis. 2022. PMID: 35580849
BACKGROUND: COVID-19 mRNA vaccines were authorized in the United States in December 2020. Although vaccine effectiveness (VE) against mild infection declines markedly after several months, limited understanding exists on the long-term durability of protection agains …
BACKGROUND: COVID-19 mRNA vaccines were authorized in the United States in December 2020. Although vaccine effectiveness (VE) …
Inferior cellular and humoral immunity against Omicron and Delta VOC compared to SARS-CoV-2 wild-type in hemodialysis patients immunized with four SARS-CoV-2 vaccine doses.
Anft M, Blazquez-Navarro A, Frahnert M, Fricke L, Meister TL, Roch T, Stervbo U, Pfaender S, Westhoff TH, Babel N. Anft M, et al. Kidney Int. 2022 May 14:S0085-2538(22)00367-2. doi: 10.1016/j.kint.2022.05.004. Online ahead of print. Kidney Int. 2022. PMID: 35580654 Free PMC article. No abstract available.
Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report.
Luciano PQ, Binatti R, Sodré AR, Zajac SR, Marson FAL, Ortega MM. Luciano PQ, et al. J Infect Public Health. 2022 Apr 25;15(6):638-642. doi: 10.1016/j.jiph.2022.04.008. Online ahead of print. J Infect Public Health. 2022. PMID: 35580449 Review.
Rare cases of unusual thrombosis and thrombocytopenia after administration of the ChAdOx1 nCoV-19 vaccine (AstraZeneca) have been reported. The unusual symptoms are called vaccine-induced immune thrombotic thrombocytopenia (VITT). ...In conclusion, it is crucial to …
Rare cases of unusual thrombosis and thrombocytopenia after administration of the ChAdOx1 nCoV-19 vaccine (AstraZeneca) have b …
Factors influencing COVID-19 vaccine acceptance and hesitancy among rural community in Bangladesh: a cross-sectional survey based study.
Roy DN, Huda MN, Azam MS. Roy DN, et al. Hum Vaccin Immunother. 2022 May 17:1-9. doi: 10.1080/21645515.2022.2064685. Online ahead of print. Hum Vaccin Immunother. 2022. PMID: 35580319
This study aims to investigate COVID-19 vaccine acceptance intention and to identify the potential factors influencing vaccine acceptance and hesitancy among the rural community in Bangladesh. ...Out of 655 rural participants, 552 (84.3%, 95% CI 81.286.8) responded …
This study aims to investigate COVID-19 vaccine acceptance intention and to identify the potential factors influencing vaccine …
A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
Martinuzzi E, Benzaquen J, Guerin O, Leroy S, Simon T, Ilie M, Hofman V, Allegra M, Tanga V, Michel E, Boutros J, Maniel C, Sicard A, Glaichenhaus N, Czerkinsky C, Blancou P, Hofman P, Marquette CH. Martinuzzi E, et al. Clin Infect Dis. 2022 May 17:ciac378. doi: 10.1093/cid/ciac378. Online ahead of print. Clin Infect Dis. 2022. PMID: 35579991
We investigated whether this was also the case for the BNT162b2 COVID-19 mRNA vaccine. METHODS: Twenty recovered COVID-19 subjects (RCS) and 23 SARS-CoV-2 naive subjects were vaccinated with respectively one and two doses of the BN …
We investigated whether this was also the case for the BNT162b2 COVID-19 mRNA vaccine. METHODS: Twenty recovered COVID- …
Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study.
Hsieh SM, Chang SC, Cheng HY, Shih SR, Lien CE. Hsieh SM, et al. Infect Dis Ther. 2022 May 17:1-12. doi: 10.1007/s40121-022-00652-6. Online ahead of print. Infect Dis Ther. 2022. PMID: 35579840 Free PMC article.
INTRODUCTION: MVC-COV1901 is a protein subunit COVID-19 vaccine based on the stable prefusion spike protein S-2P adjuvanted with CpG 1018 and aluminum hydroxide. ...Immunogenicity and antibody persistence for up to 6 months after the booster dose were assessed by ne …
INTRODUCTION: MVC-COV1901 is a protein subunit COVID-19 vaccine based on the stable prefusion spike protein S-2P adjuvanted wi …
Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
Weitzman ER, Kossowsky J, Blakemore LM, Cox R, Dowling DJ, Levy O, Needles EW, Levy S. Weitzman ER, et al. Clin Infect Dis. 2022 May 17:ciac344. doi: 10.1093/cid/ciac344. Online ahead of print. Clin Infect Dis. 2022. PMID: 35579508
OBJECTIVE: The opioid epidemic worsened during the COVID-19 pandemic. Synthetic opioids (primarily fentanyl) comprise the most common drugs involved in overdose (OD) death. ...
OBJECTIVE: The opioid epidemic worsened during the COVID-19 pandemic. Synthetic opioids (primarily fentanyl) comprise the most …
Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
Weitzman ER, Sherman AC, Levy O. Weitzman ER, et al. Clin Infect Dis. 2022 May 17:ciac343. doi: 10.1093/cid/ciac343. Online ahead of print. Clin Infect Dis. 2022. PMID: 35579499
Authorization of SARS-CoV-2 vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions and …
Authorization of SARS-CoV-2 vaccines for children has ushered in a new phase of the immunization campaign to add …
Post COVID-19 Vaccination acute Disseminated Encephalomyelitis: A case report.
Garg A, Batra PK, Gupta P. Garg A, et al. Curr Med Imaging. 2022 May 9. doi: 10.2174/1573405618666220509205457. Online ahead of print. Curr Med Imaging. 2022. PMID: 35579135
CASE PRESENTATION: The patient's main concerns and important clinical findings-The patient had a history of COVID -19 vaccination [recombinant ChAdOX1 nCoV-19] 14 days prior to the symptoms. ...CONCLUSION: The clinical exam, location, sparse contrast e …
CASE PRESENTATION: The patient's main concerns and important clinical findings-The patient had a history of COVID -19 vaccinat …
Hyper-eosinophilic syndrome with myocarditis after inactivated SARS-CoV-2 vaccination - a case study.
Tiwari A, Karna G, Chakrabati SS, Panda PK, Kaur U. Tiwari A, et al. Curr Drug Saf. 2022 May 9. doi: 10.2174/1574886317666220509165317. Online ahead of print. Curr Drug Saf. 2022. PMID: 35579125
INTRODUCTION: COVID-19 vaccine induced serious adverse reactions are rare. Hyper-eosinophilia syndrome with myocarditis has not been reported earlier following BBV152 vaccine administration. ...CONCLUSION: This is the first reported case of hyper-eosinophilia …
INTRODUCTION: COVID-19 vaccine induced serious adverse reactions are rare. Hyper-eosinophilia syndrome with myocarditis …
Public Opinion and Sentiment Before and at the Beginning of COVID-19 Vaccinations in Japan: Twitter Analysis.
Niu Q, Liu J, Kato M, Shinohara Y, Matsumura N, Aoyama T, Nagai-Tanima M. Niu Q, et al. JMIR Infodemiology. 2022 May 9;2(1):e32335. doi: 10.2196/32335. eCollection 2022 Jan-Jun. JMIR Infodemiology. 2022. PMID: 35578643 Free PMC article.
BACKGROUND: COVID-19 vaccines are considered one of the most effective ways for containing the COVID-19 pandemic, but Japan lagged behind other countries in vaccination in the early stages. ...METHODS: We collected 144,101 Japanese tweets containing …
BACKGROUND: COVID-19 vaccines are considered one of the most effective ways for containing the COVID-19 pandemic …
Environmental impact of COVID-19 Vaccine waste: A perspective on potential role of natural and biodegradable materials.
Hasija V, Patial S, Kumar A, Singh P, Ahamad T, Khan AAP, Raizada P, Hussain CM. Hasija V, et al. J Environ Chem Eng. 2022 May 11:107894. doi: 10.1016/j.jece.2022.107894. Online ahead of print. J Environ Chem Eng. 2022. PMID: 35578627 Free PMC article.
The mass immunization is the prioritised post-pandemic phase offering preventive countermeasure for COVID-19 pandemic. However, it is crucial to tackle the environmental impact of COVID-19 vaccine waste for sustainable vaccination management because a …
The mass immunization is the prioritised post-pandemic phase offering preventive countermeasure for COVID-19 pandemic. However …
Microscopic Polyangiitis Following mRNA COVID-19 Vaccination: A Case Report.
So D, Min KW, Jung WY, Han SW, Yu MY. So D, et al. J Korean Med Sci. 2022 May 16;37(19):e154. doi: 10.3346/jkms.2022.37.e154. J Korean Med Sci. 2022. PMID: 35578586
Coronavirus disease 2019 (COVID-19) is one of the most widespread viral infections in human history. ...He had no medical history other than being treated for tuberculosis last year. Although his renal function was normal at last year, acute
Coronavirus disease 2019 (COVID-19) is one of the most widespread viral infections in human history. ...H
Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers.
Kwon SR, Kim N, Park H, Minn D, Park S, Roh EY, Yoon JH, Shin S. Kwon SR, et al. J Korean Med Sci. 2022 May 16;37(19):e135. doi: 10.3346/jkms.2022.37.e135. J Korean Med Sci. 2022. PMID: 35578582
Despite strict guidelines for coronavirus disease 2019 (COVID-19), South Korea is facing its fourth pandemic wave. ...We also showed the booster dose (the third dose) increased antibody titer by average 14 (min-max, 2-255)-fold higher com …
Despite strict guidelines for coronavirus disease 2019 (COVID-19), South Korea is facing its fourth pande …
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.
Cao Z, Zhang C, Zhao S, Sheng Z, Xiang X, Li R, Qian Z, Wang Y, Chen B, Li Z, Liu Y, An B, Zhou H, Cai W, Wang H, Gui H, Xin H, Xie Q. Cao Z, et al. Infect Dis Poverty. 2022 May 16;11(1):56. doi: 10.1186/s40249-022-00982-0. Infect Dis Poverty. 2022. PMID: 35578350
BACKGROUND: Safety data reported from the large-scale clinical trials of the coronavirus disease 2019 (COVID-19) vaccine are extremely limited in patients with decompensated cirrhosis. ...The safety analysis demonstrated that 75.3% had no advers …
BACKGROUND: Safety data reported from the large-scale clinical trials of the coronavirus disease 2019 (COVID- …
Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
Novembre E, Tosca M, Caffarelli C, Calvani M, Cardinale F, Castagnoli R, Chiappini E, Cravidi C, Del Giudice MM, Duse M, Licari A, Manti S, Martelli A, Ricci G, Pingitore G, Marseglia GL. Novembre E, et al. Ital J Pediatr. 2022 May 16;48(1):76. doi: 10.1186/s13052-022-01272-z. Ital J Pediatr. 2022. PMID: 35578294 Review.
In some cases, a correct allergic evaluation allows identifying patients at risk of developing an anaphylactic reaction. Risk assessment of allergic reactions to COVID-19 vaccines is useful to limit contraindications to vaccination and help to safely vaccinate peopl …
In some cases, a correct allergic evaluation allows identifying patients at risk of developing an anaphylactic reaction. Risk assessment of …
Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study.
Omidvar S, Firouzbakht M. Omidvar S, et al. BMC Health Serv Res. 2022 May 16;22(1):652. doi: 10.1186/s12913-022-07948-w. BMC Health Serv Res. 2022. PMID: 35578251
BACKGROUND: Iran had a high rate of death in several COVID 19 waves. Vaccination is a method for prevention and control of the COVID-19 pandemic. ...It is also dependent on the global acceptance and vaccine coverage rate. This study aimed to determine …
BACKGROUND: Iran had a high rate of death in several COVID 19 waves. Vaccination is a method for prevention and control of the …
Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey.
Su J, Jia Z, Wang X, Qin F, Chen R, Wu Y, Lu B, Lan C, Qin T, Liao Y, Shi M, Liao Y, Pan P, Ye L, Jiang J, Liang H. Su J, et al. BMC Infect Dis. 2022 May 16;22(1):471. doi: 10.1186/s12879-022-07452-w. BMC Infect Dis. 2022. PMID: 35578187
BACKGROUND: Vaccination has been proven to be an effective approach against the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine the acceptance rate and factors influencing acceptance of COVID-19 vaccinat …
BACKGROUND: Vaccination has been proven to be an effective approach against the coronavirus disease 2019 (COVID- …
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.
Rosner A, Steiner M, Melamed S, Politi B, Vitner E, Tamir H, Achdout H, Cherry L, Avraham R, Yahalom-Ronen Y, Levy H, Beth-Din A, Stein D, Mechaly A, Fisher M, Fatelevich E, Weiss S, Kronfeld N, Madar-Shapiro L, Nyska A, Yitzhaki S, Paran N, Israely T, Marcus H, Madar-Balakirski N. Rosner A, et al. Arch Toxicol. 2022 May 17:1-11. doi: 10.1007/s00204-022-03302-5. Online ahead of print. Arch Toxicol. 2022. PMID: 35577986 Free PMC article.
BriLife(), a vector-based vaccine that utilizes the recombinant vesicular stomatitis virus (VSV) platform to express and present the spike antigen of SARS-CoV-2, is undergoing testing in a phase 2 clinical trial in Israel. ...In view of the find …
BriLife(), a vector-based vaccine that utilizes the recombinant vesicular stomatitis virus (VSV) platform to express and present the …
Effectiveness of COVID-19 vaccination among people living with HIV during a COVID-19 outbreak.
Lin KY, Wu PY, Liu WD, Sun HY, Hsieh SM, Sheng WH, Huang YS, Hung CC, Chang SC. Lin KY, et al. J Microbiol Immunol Infect. 2022 May 5:S1684-1182(22)00060-3. doi: 10.1016/j.jmii.2022.04.006. Online ahead of print. J Microbiol Immunol Infect. 2022. PMID: 35577735 Free PMC article.
COVID-19 vaccination is recommended for at-risk populations, but the vaccine effectiveness in people living with HIV (PLWH) remains incompletely understood. Here we demonstrate that COVID-19 vaccination was clinically effective among PLWH during the ou
COVID-19 vaccination is recommended for at-risk populations, but the vaccine effectiveness in people living with HIV (PLWH) re
Central serous chorioretinopathy following the BNT162b2 mRNA vaccine.
Hanhart J, Roditi E, Wasser LM, Barhoum W, Zadok D, Brosh K. Hanhart J, et al. J Fr Ophtalmol. 2022 May 13:S0181-5512(22)00134-6. doi: 10.1016/j.jfo.2022.01.006. Online ahead of print. J Fr Ophtalmol. 2022. PMID: 35577701 Free PMC article.
BACKGROUND AND PURPOSE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has accelerated vaccine development. ...RESULTS: Four patients (3 males, 1 female) between the ages of 35 and 65 presented with a
BACKGROUND AND PURPOSE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV- …
Adverse events after BNT162b2 mRNA COVID-19 vaccination in health care workers and medical students in Japan.
Namiki T, Komine-Aizawa S, Takada K, Takano C, Trinh QD, Hayakawa S. Namiki T, et al. J Infect Chemother. 2022 May 11:S1341-321X(22)00151-9. doi: 10.1016/j.jiac.2022.05.002. Online ahead of print. J Infect Chemother. 2022. PMID: 35577684 Free PMC article.
To control the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the promotion of vaccination is important. ...Fur …
To control the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute resp
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Kumar Suri R, Hayman B, Prasad SD, Makhoana M, Tippoo P. Kumar Suri R, et al. Vaccine. 2022 May 13:S0264-410X(22)00576-X. doi: 10.1016/j.vaccine.2022.05.006. Online ahead of print. Vaccine. 2022. PMID: 35577632 Free PMC article.
The development and scaled-up production of several safe and effective vaccines against COVID-19 resulted in over 12 billion doses being produced by the end of 2021. ...The ability to acquire technology, access markets and financing mechanisms, and workforce develop …
The development and scaled-up production of several safe and effective vaccines against COVID-19 resulted in over 12 billion d …
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Duc Dang A, Dinh Vu T, Hai Vu H, Thanh Ta V, Thi Van Pham A, Thi Ngoc Dang M, Van Le B, Huu Duong T, Van Nguyen D, Lawpoolsri S, Chinwangso P, McLellan JS, Hsieh CL, Garcia-Sastre A, Palese P, Sun W, Martinez JL, Gonzalez-Dominguez I, Slamanig S, Manuel Carreño J, Tcheou J, Krammer F, Raskin A, Minh Vu H, Cong Tran T, Mai Nguyen H, Mercer LD, Raghunandan R, Lal M, White JA, Hjorth R, Innis BL, Scharf R. Duc Dang A, et al. Vaccine. 2022 May 13:S0264-410X(22)00526-6. doi: 10.1016/j.vaccine.2022.04.078. Online ahead of print. Vaccine. 2022. PMID: 35577631 Free PMC article.
Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based Newcastle disease virus (NDV) vaccine expressing the spike protein of sev
Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries …
National safety surveillance of quadrivalent recombinant influenza vaccine in Taiwan during NH 20/21.
Tsai SY, Yeh TY, Chiu NC, Huang CT. Tsai SY, et al. Vaccine. 2022 May 13:S0264-410X(22)00588-6. doi: 10.1016/j.vaccine.2022.05.017. Online ahead of print. Vaccine. 2022. PMID: 35577629 Free PMC article.
BACKGROUND: During the COVID-19 pandemic, the need for influenza vaccine significantly increased in the initial weeks of the 2020-2021 influenza vaccination campaign season in Taiwan. ...
BACKGROUND: During the COVID-19 pandemic, the need for influenza vaccine significantly increased in the initial weeks of the 2 …
Reduced neutralizing antibody potency of COVID-19 convalescent vaccinated plasma against SARS-CoV-2 Omicron variant.
Gallian P, Amroun A, Laperche S, Le Cam S, Brisbarre N, Malard L, Nurtop E, Isnard C, Richard P, Morel P, Tiberghien P, de Lamballerie X. Gallian P, et al. Vox Sang. 2022 May 16. doi: 10.1111/vox.13279. Online ahead of print. Vox Sang. 2022. PMID: 35577569
BACKGROUND AND OBJECTIVE: The SARS-CoV-2 Omicron variant displays increased infectiveness as well as mutations resulting in reduced neutralizing activity of antibodies acquired after vaccination or infection involving earlier strains. To assess the ability of …
BACKGROUND AND OBJECTIVE: The SARS-CoV-2 Omicron variant displays increased infectiveness as well as mutations resultin …
COVID-19 Vaccines and Potential Implications for COVID-19-Specific Obsessive-Compulsive Disorder Presentations.
Wiese AD, Wojcik KD, Omar Y. Wiese AD, et al. J Cogn Psychother. 2022 May 1;36(2):102-111. doi: 10.1891/JCP-2021-0019. J Cogn Psychother. 2022. PMID: 35577517
Public health crises, including the ongoing COVID-19 pandemic, have wide reaching implications on mental health, and have resulted in unique OCD presentations specific to respective crises. The distribution of highly efficacious and effective vaccines for COVID
Public health crises, including the ongoing COVID-19 pandemic, have wide reaching implications on mental health, and have resu …
Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers.
Petito E, Colonna E, Falcinelli E, Mezzasoma AM, Cesari E, Giglio E, Fiordi T, Almerigogna F, Villa A, Gresele P. Petito E, et al. Br J Haematol. 2022 May 16. doi: 10.1111/bjh.18245. Online ahead of print. Br J Haematol. 2022. PMID: 35577507
To slow down the coronavirus disease 2019 (COVID-19) pandemic an unequalled vaccination campaign was initiated. ...While a few studies have evaluated the incidence of anti-PF4 positivity in anti-severe acute respiratory s
To slow down the coronavirus disease 2019 (COVID-19) pandemic an unequalled vaccination campaign was init …
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE).
Tran AP, Tassone D, Nossent J, Ding NS. Tran AP, et al. RMD Open. 2022 May;8(1):e002301. doi: 10.1136/rmdopen-2022-002301. RMD Open. 2022. PMID: 35577478 Free article.
OBJECTIVE: To assess the antibody response to disease-modifying antirheumatic drug (DMARD) therapy after the first and second dose of the ChAdOx1nCov-19 (AstraZeneca (AZ)) and BNT162b (Pfizer) vaccines in patients with immune-mediated inflammatory disease (IM …
OBJECTIVE: To assess the antibody response to disease-modifying antirheumatic drug (DMARD) therapy after the first and second dose of …
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine.
Atalis A, Keenum MC, Pandey B, Beach A, Pradhan P, Vantucci C, O'Farrell L, Noel R, Jain R, Hosten J, Smith C, Kramer L, Jimenez A, Ochoa MA, Frey D, Roy K. Atalis A, et al. J Control Release. 2022 May 13:S0168-3659(22)00285-1. doi: 10.1016/j.jconrel.2022.05.023. Online ahead of print. J Control Release. 2022. PMID: 35577151
Despite success in vaccinating populations against SARS-CoV-2, concerns about immunity duration, continued efficacy against emerging variants, protection from infection and transmission, and worldwide vaccine availability remain. ...These results suggest that …
Despite success in vaccinating populations against SARS-CoV-2, concerns about immunity duration, continued efficacy aga …
Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K, Khan SA, Jalal K, Ul-Haq Z, Uddin R. Khan K, et al. Virology. 2022 May 10;572:28-43. doi: 10.1016/j.virol.2022.05.001. Online ahead of print. Virology. 2022. PMID: 35576833 Free PMC article.
The newly discovered SARS-CoV-2 Omicron variant B.1.1.529 is a Variant of Concern (VOC) announced by the World Health Organization (WHO). ...As a result, we need effective vaccination that can tackle Omicron SARS-CoV-2 variants that are b …
The newly discovered SARS-CoV-2 Omicron variant B.1.1.529 is a Variant of Concern (VOC) announced by the World Health O …
Active viral shedding in a vaccinated hospitalized patient infected with the delta variant (B.1.617.2) of SARS-CoV-2 and challenges of de-isolation.
Alshukairi AN, Al-Omari A, Al-Tawfiq JA, El-Kafrawy SA, El-Daly MM, Hassan AM, Faizo AA, Alandijany TA, Dada A, Saeedi MF, Alhamlan FS, Al Hroub MK, Qushmaq I, Azhar EI. Alshukairi AN, et al. J Infect Public Health. 2022 Apr 28;15(6):628-630. doi: 10.1016/j.jiph.2022.04.011. Online ahead of print. J Infect Public Health. 2022. PMID: 35576779 Free PMC article.
In the era of SARS-CoV-2 variants and COVID-19 vaccination, the duration of infectious viral shedding and isolation in post vaccine breakthrough infections is challenging and depends on disease severity. The current study described a case …
In the era of SARS-CoV-2 variants and COVID-19 vaccination, the duration of infectious viral shedding and …
The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines.
Wei J, Hui AM. Wei J, et al. Cancer Treat Rev. 2022 May 5;107:102405. doi: 10.1016/j.ctrv.2022.102405. Online ahead of print. Cancer Treat Rev. 2022. PMID: 35576777 Free PMC article. Review.
mRNA vaccines have gained popularity over the last decade as a versatile tool for developing novel therapeutics. The recent success of coronavirus disease (COVID-19) mRNA vaccine has unlocked the potential of mRNA technology as a powerful therap …
mRNA vaccines have gained popularity over the last decade as a versatile tool for developing novel therapeutics. The recent success o …
Risk factors and the impact of vaccination on mortality in COVID-19 patients.
Sezen YI, Senoglu S, Karabela SN, Yesilbag Z, Borcak D, Canbolat Unlu E, Korkusuz R, Ozdemir Y, Kart Yasar K. Sezen YI, et al. Bratisl Lek Listy. 2022;123(6):440-443. doi: 10.4149/BLL_2022_068. Bratisl Lek Listy. 2022. PMID: 35576546
INTRODUCTION: The novel coronavirus disease (COVID-19) pandemic has had a profound global impact economically, socially, and in many other areas. ...Our findings support that full vaccination reduces COVID-19 -related mortality rat …
INTRODUCTION: The novel coronavirus disease (COVID-19) pandemic has had a profound global impact economic …
Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer.
Iriagac Y, Cavdar E, Karaboyun K, Avci O, Alan O, Taskaynatan H, Celikkol A, Kara SP, Erdal B, Seber ES. Iriagac Y, et al. Bratisl Lek Listy. 2022;123(6):401-407. doi: 10.4149/BLL_2022_063. Bratisl Lek Listy. 2022. PMID: 35576541
OBJECTIVE: To compare seroconversion for SARS-CoV-2 receptor-binding domain (RBD) specific IgG positivity against two doses of the CoronaVac vaccine in breast and lung cancer patients receiving systemic therapy, to determine the factors affecting seropositivi …
OBJECTIVE: To compare seroconversion for SARS-CoV-2 receptor-binding domain (RBD) specific IgG positivity against two d …
Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
Hayer J, Urlaub E. Hayer J, et al. Microbiol Spectr. 2022 May 16:e0270921. doi: 10.1128/spectrum.02709-21. Online ahead of print. Microbiol Spectr. 2022. PMID: 35575594
The study aimed to establish the performance of the SARS-CoV-2 Rapid Antibody Test (IgG and IgM) and the Elecsys Anti-SARS-CoV-2 S assay in vaccinated individuals. ...Agreement of the SARS-CoV-2 Rapid Antibody Test (I …
The study aimed to establish the performance of the SARS-CoV-2 Rapid Antibody Test (IgG and IgM) and the Elecsys Anti- …
The changing vaccine landscape: rates of COVID-19 vaccine acceptance and hesitancy in young adults during vaccine rollout.
Knight H, Jia R, Ayling K, Blake H, Morling JR, Villalon AM, Corner J, Denning C, Ball J, Bolton K, Figueredo G, Morris D, Tighe P, Vedhara K. Knight H, et al. Perspect Public Health. 2022 May 15:17579139221094750. doi: 10.1177/17579139221094750. Online ahead of print. Perspect Public Health. 2022. PMID: 35575215
AIMS: Development and rollout of vaccines offers the best opportunity for population protection against the SARS-CoV-2 (COVID-19) virus. However, hesitancy towards the vaccines might impede successful uptake in the United Kingdom, particu …
AIMS: Development and rollout of vaccines offers the best opportunity for population protection against the SARS-CoV-2
COVID-19 Vaccinations and Anxiety in Middle-Aged and Older Jews and Arabs in Israel: The Moderating Roles of Ethnicity and Subjective Age.
Bergman YS, Palgi Y, Ben-David B, Bodner E. Bergman YS, et al. J Appl Gerontol. 2022 May 16:7334648221092029. doi: 10.1177/07334648221092029. Online ahead of print. J Appl Gerontol. 2022. PMID: 35575162 Free PMC article.
., feeling younger/older than one's chronological age) plays a significant role in older minority group members' psychological well-being. In light of the importance of vaccinations for fighting COVID-19, it is unclear whether ethnicity and subjective age moderate t …
., feeling younger/older than one's chronological age) plays a significant role in older minority group members' psychological well-being. I …
COVID-19 and cardiovascular disease: Manifestations, pathophysiology, vaccination, and long-term implication.
Abdel Moniem A, Radwan MA, Yousef AI. Abdel Moniem A, et al. Curr Med Res Opin. 2022 May 14:1-23. doi: 10.1080/03007995.2022.2078081. Online ahead of print. Curr Med Res Opin. 2022. PMID: 35575011 Review.
The coronavirus disease 2019 (COVID-19) pandemic is caused by a new coronavirus family member, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is linke …
The coronavirus disease 2019 (COVID-19) pandemic is caused by a new coronavirus family memb …
Acculturation, trust to health care system, and attitudes to COVID-19 vaccination: A comparative study between Polish immigrants in Norway, Polish in Poland, and Norwegians in Norway.
Lajunen T, Wróbel B. Lajunen T, et al. Curr Res Ecol Soc Psychol. 2022;3:100047. doi: 10.1016/j.cresp.2022.100047. Epub 2022 May 7. Curr Res Ecol Soc Psychol. 2022. PMID: 35574266 Free PMC article.
Fast deployment of safe and efficient COVID-19 vaccines has changed the course of the pandemic in many countries reducing COVID-19 death rates and allowing countries to abandon strict measures such as social distancing and restrictions to public events …
Fast deployment of safe and efficient COVID-19 vaccines has changed the course of the pandemic in many countries reducing C
Facial and Abducens Nerve Palsies Following COVID-19 Vaccination: Report of Two Cases.
Veisi A, Najafi M, Hassanpour K, Bagheri A. Veisi A, et al. Neuroophthalmology. 2022 Feb 15;46(3):203-206. doi: 10.1080/01658107.2022.2032204. eCollection 2022. Neuroophthalmology. 2022. PMID: 35574171
A broad spectrum of neurological side effects has been reported after immunisation for COVID-19, including functional neurological disorders, cerebral vascular events, cerebral venous thrombosis, intracerebral haemorrhage, neuroleptic malignant syndrome, cran …
A broad spectrum of neurological side effects has been reported after immunisation for COVID-19, including functional neurolog …
Coronavirus Disease 2019 Vaccination During Pregnancy and Breastfeeding: A Review of Evidence and Current Recommendations in Europe, North America, and Australasia.
Pietrasanta C, Ronchi A, Crippa BL, Artieri G, Ballerini C, Crimi R, Mosca F, Pugni L. Pietrasanta C, et al. Front Pediatr. 2022 Apr 29;10:883953. doi: 10.3389/fped.2022.883953. eCollection 2022. Front Pediatr. 2022. PMID: 35573944 Free PMC article. Review.
In the late 2020s, less than 1 year into the coronavirus disease 2019 (COVID-19) pandemic, several anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines were int …
In the late 2020s, less than 1 year into the coronavirus disease 2019 (COVID-19) pandemic, several anti- …
An Immunoinformatic Strategy to Develop New Mycobacterium tuberculosis Multi-epitope Vaccine.
Ghandadi M. Ghandadi M. Int J Pept Res Ther. 2022;28(3):99. doi: 10.1007/s10989-022-10406-0. Epub 2022 May 10. Int J Pept Res Ther. 2022. PMID: 35573911 Free PMC article.
Mycobacterium tuberculosis causes a life-threatening disease known as tuberculosis (TB). In 2021, tuberculosis was the second cause of death after COVID-19 among infectious diseases. ...Here, a multi-epitope vaccine have been designed against TB using five …
Mycobacterium tuberculosis causes a life-threatening disease known as tuberculosis (TB). In 2021, tuberculosis was the second cause o …
Comparing the Nucleocapsid Proteins of Human Coronaviruses: Structure, Immunoregulation, Vaccine, and Targeted Drug.
Zhang B, Tian J, Zhang Q, Xie Y, Wang K, Qiu S, Lu K, Liu Y. Zhang B, et al. Front Mol Biosci. 2022 Apr 29;9:761173. doi: 10.3389/fmolb.2022.761173. eCollection 2022. Front Mol Biosci. 2022. PMID: 35573742 Free PMC article. Review.
The seven pathogenic human coronaviruses (HCoVs) include HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1, which usually cause mild upper respiratory tract diseases, and SARS-CoV, MERS-CoV, and SARS-CoV-2, which cause a sev
The seven pathogenic human coronaviruses (HCoVs) include HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1, which usually cause mild upp …
Gastrointestinal Complications of COVID-19 Vaccines.
Ajmera K, Bansal R, Wilkinson H, Goyal L. Ajmera K, et al. Cureus. 2022 Apr 12;14(4):e24070. doi: 10.7759/cureus.24070. eCollection 2022 Apr. Cureus. 2022. PMID: 35573556 Free PMC article.
Much of the control over the coronavirus disease 2019 (COVID-19) pandemic has been achieved by mass vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2
Much of the control over the coronavirus disease 2019 (COVID-19) pandemic has been achieved by mass vacci …
Symptomatic Myocarditis Post COVID-19 Vaccination.
Patel P, Desai D, Ganta N, Tadepalli S, Kata P, Kanukuntla A, Schoenfeld M, Sathya B, Okere A. Patel P, et al. Cureus. 2022 Apr 11;14(4):e24052. doi: 10.7759/cureus.24052. eCollection 2022 Apr. Cureus. 2022. PMID: 35573513 Free PMC article.
There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, increasing cases of myocarditis and pericarditis are being reported to the Vaccine Adverse Event Reporting System (VAERS) in young people, pri …
There are few major adverse events after the coronavirus disease 2019 (COVID-19) vaccination. However, in …
Comorbidities and Symptomatology of SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-Related Myocarditis and SARS-CoV-2 Vaccine-Related Myocarditis: A Review.
Cushion S, Arboleda V, Hasanain Y, Demory Beckler M, Hardigan P, Kesselman MM. Cushion S, et al. Cureus. 2022 Apr 12;14(4):e24084. doi: 10.7759/cureus.24084. eCollection 2022 Apr. Cureus. 2022. PMID: 35573496 Free PMC article. Review.
The primary etiology of myocarditis is a viral infection, with studies demonstrating that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to myocarditis. ...This review aims to cha …
The primary etiology of myocarditis is a viral infection, with studies demonstrating that infection with severe acute respi
Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine.
Desai AD, Shah R, Haroon A, Wassef C. Desai AD, et al. Cureus. 2022 Apr 13;14(4):e24126. doi: 10.7759/cureus.24126. eCollection 2022 Apr. Cureus. 2022. PMID: 35573488 Free PMC article.
As the onset of novel variants of the severe acute respiratory syndrome coronavirus 2 virus pushes policy-makers to push widespread vaccination efforts, it is likely that an increased number of severe cutaneous advers …
As the onset of novel variants of the severe acute respiratory syndrome coronavirus 2 vi
Predicting COVID-19 vaccine hesitancy in Hong Kong: Vaccine knowledge, risks from coronavirus, and risks and benefits of vaccination.
Tsang SJ. Tsang SJ. Vaccine X. 2022 Aug;11:100164. doi: 10.1016/j.jvacx.2022.100164. Epub 2022 Apr 29. Vaccine X. 2022. PMID: 35573268 Free PMC article.
INTRODUCTION: Hongkongers have had access to COVID-19 vaccines for about four months, but vaccination rate remains low (34.4% as of 4 July 2021). ...A series of analyses of covariance was performed to inspect differences among the groups and multiple regression anal …
INTRODUCTION: Hongkongers have had access to COVID-19 vaccines for about four months, but vaccination rate remains low (34.4% …
Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future Perspectives.
Nakada H, Takashima K, Maru Y, Ikka T, Yuji K, Yoshida S, Matsui K. Nakada H, et al. Asian Bioeth Rev. 2022 May 11:1-16. doi: 10.1007/s41649-022-00207-4. Online ahead of print. Asian Bioeth Rev. 2022. PMID: 35573157 Free PMC article.
Improving public understanding and acceptance are critical for promoting coronavirus (COVID-19) vaccination. However, how to promote COVID-19 vaccine programs remains controversial due to various ethical issues. ...Possible reasons for the older …
Improving public understanding and acceptance are critical for promoting coronavirus (COVID-19) vaccination. However, h …
Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine.
Bensaidane MR, Picher-Martel V, Émond F, De Serres G, Dupré N, Beauchemin P. Bensaidane MR, et al. Front Neurol. 2022 Apr 29;13:872734. doi: 10.3389/fneur.2022.872734. eCollection 2022. Front Neurol. 2022. PMID: 35572945 Free PMC article.
"It has recently been reported in association with coronavirus disease 2019 (COVID-19) infection. METHODS: A 56-year-old male with a diagnosis of ANE 48 h following the first dose of ChAdOx1 nCoV-19 vaccination was investigated. .. …
"It has recently been reported in association with coronavirus disease 2019 (COVID-19) infection. METHODS …
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
Quintanilla-Bordás C, Gascón-Gimenez F, Alcalá C, Payá M, Mallada J, Silla R, Carratalà-Boscà S, Gasque-Rubio R, Castillo J, Casanova B. Quintanilla-Bordás C, et al. Front Neurol. 2022 Apr 27;13:897275. doi: 10.3389/fneur.2022.897275. eCollection 2022. Front Neurol. 2022. PMID: 35572939 Free PMC article.
INTRODUCTION: mRNA coronavirus disease 2019 (COVID-19) vaccination has been widely used to arrest the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pande …
INTRODUCTION: mRNA coronavirus disease 2019 (COVID-19) vaccination has been widely used to arrest the spr …
Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study.
Chadeau-Hyam M, Eales O, Bodinier B, Wang H, Haw D, Whitaker M, Elliott J, Walters CE, Jonnerby J, Atchison C, Diggle PJ, Page AJ, Ashby D, Barclay W, Taylor G, Cooke G, Ward H, Darzi A, Donnelly CA, Elliott P. Chadeau-Hyam M, et al. EClinicalMedicine. 2022 Jun;48:101419. doi: 10.1016/j.eclinm.2022.101419. Epub 2022 May 6. EClinicalMedicine. 2022. PMID: 35572721 Free PMC article.
BACKGROUND: Prevalence of SARS-CoV-2 infection with Delta variant was increasing in England in late summer 2021 among children aged 5 to 17 years, and adults who had received two vaccine doses. In September 2021, a third (booster) dose was offered to vaccinat …
BACKGROUND: Prevalence of SARS-CoV-2 infection with Delta variant was increasing in England in late summer 2021 among c …
Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants.
Li C, Guo Y, Fang Z, Zhang H, Zhang Y, Chen K. Li C, et al. Front Immunol. 2022 Apr 28;13:804945. doi: 10.3389/fimmu.2022.804945. eCollection 2022. Front Immunol. 2022. PMID: 35572594 Free PMC article. Review.
The outbreak of COVID-19 (caused by SARS-CoV-2) has posed a significant threat to global public health security because of its high pathogenicity and infectivity. To date, the pathogenic mechanism of this novel coronavirus (SARS
The outbreak of COVID-19 (caused by SARS-CoV-2) has posed a significant threat to global public health se …
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects.
Zhang Z, Shen Q, Chang H. Zhang Z, et al. Front Immunol. 2022 Apr 27;13:843928. doi: 10.3389/fimmu.2022.843928. eCollection 2022. Front Immunol. 2022. PMID: 35572592 Free PMC article. Review.
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public health all o …
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines.
Liu J, Mao Q, Wu X, He Q, Bian L, Bai Y, Wang Z, Wang Q, Zhang J, Liang Z, Xu M. Liu J, et al. Front Immunol. 2022 Apr 27;13:814365. doi: 10.3389/fimmu.2022.814365. eCollection 2022. Front Immunol. 2022. PMID: 35572565 Free PMC article. Review.
To effectively control and prevent the pandemic of coronavirus disease 2019 (COVID-19), suitable vaccines have been researched and developed rapidly. ...The considerations discussed here open up new avenues for devising novel appro …
To effectively control and prevent the pandemic of coronavirus disease 2019 (COVID-19), suitable vaccines …
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
Antolí A, Rocamora-Blanch G, Framil M, Mas-Bosch V, Navarro S, Bermudez C, Martinez-Yelamos S, Dopico E, Calatayud L, Garcia-Muñoz N, Hernández-Benítez LH, Riera-Mestre A, Bas J, Masuet-Aumatell C, Rigo-Bonnin R, Morandeira F, Solanich X. Antolí A, et al. Front Immunol. 2022 Apr 29;13:895209. doi: 10.3389/fimmu.2022.895209. eCollection 2022. Front Immunol. 2022. PMID: 35572562 Free PMC article.
INTRODUCTION: SARS-CoV-2 vaccines' effectiveness is not yet clearly known in immunocompromised patients. ...Participants with prior SARS-CoV-2 infection; or prior SARS-CoV-2 vaccine administration; or use of any immun …
INTRODUCTION: SARS-CoV-2 vaccines' effectiveness is not yet clearly known in immunocompromised patients. ...Participant …
Markers of Memory CD8 T Cells Depicting the Effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan.
Kondo H, Kageyama T, Tanaka S, Otsuka K, Tsukumo SI, Mashimo Y, Onouchi Y, Nakajima H, Yasutomo K. Kondo H, et al. Front Immunol. 2022 Apr 28;13:836923. doi: 10.3389/fimmu.2022.836923. eCollection 2022. Front Immunol. 2022. PMID: 35572546 Free PMC article.
BNT162b2, a nucleoside-modified mRNA vaccine for SARS-CoV-2 spike glycoprotein (S), provides approximately 95% efficacy for preventing COVID-19. ...
BNT162b2, a nucleoside-modified mRNA vaccine for SARS-CoV-2 spike glycoprotein (S), provides approximately 95% efficacy …
Vaccine production and supply need a paradigm change.
Kritharis A, Tamer IM, Yadav VG. Kritharis A, et al. Can J Chem Eng. 2022 May 4:10.1002/cjce.24399. doi: 10.1002/cjce.24399. Online ahead of print. Can J Chem Eng. 2022. PMID: 35572455 Free PMC article.
We discuss the impact of COVID-19, the journey towards developing vaccines against the disease, and how biomanufacturing should evolve in order to meet similar challenges in the future....
We discuss the impact of COVID-19, the journey towards developing vaccines against the disease, and how biomanufacturin …
Set-Valued Control to COVID-19 Spread with Treatment and Limitation of Vaccination Resources.
Boujallal L, Elhia M. Boujallal L, et al. Iran J Sci Technol Trans A Sci. 2022 May 8:1-10. doi: 10.1007/s40995-022-01295-5. Online ahead of print. Iran J Sci Technol Trans A Sci. 2022. PMID: 35572224 Free PMC article.
In this paper, we consider an SEIR model that describes the dynamics of the COVID-19 pandemic. Subject to this model with vaccination and treatment as controls, we formulate a control problem that aims to reduce the number of infectious individuals to zero. ...
In this paper, we consider an SEIR model that describes the dynamics of the COVID-19 pandemic. Subject to this model with vacc …
Case Report: Importance of MRI Examination in the Diagnosis and Evaluation of COVID-19 mRNA Vaccination Induced Myocarditis: Our Experience and Literature Review.
Watanabe K, Ashikaga T, Maejima Y, Tao S, Terui M, Kishigami T, Kaneko M, Nakajima R, Okata S, Lee T, Horie T, Nagase M, Nitta G, Miyazaki R, Nagamine S, Nagata Y, Nozato T, Goya M, Sasano T. Watanabe K, et al. Front Cardiovasc Med. 2022 Apr 27;9:844626. doi: 10.3389/fcvm.2022.844626. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35571222 Free PMC article.
Acute myocarditis is a rare but serious complication associated with mRNA-based coronavirus disease 2019 (COVID-19) vaccination. ...According to a report by the U.S. Centers for Disease Control and Prevention (CDC), the diagnosis o
Acute myocarditis is a rare but serious complication associated with mRNA-based coronavirus disease 2019 (COV
Case Report: Transient Increase of CMR T1 Mapping Indices in a Patient With COVID-19 mRNA Vaccine Induced Acute Myocarditis.
Ansari U, Britsch S, Rogowski S, Duerschmied D, Papavassiliu T. Ansari U, et al. Front Cardiovasc Med. 2022 Apr 27;9:880717. doi: 10.3389/fcvm.2022.880717. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35571183 Free PMC article.
BACKGROUND: Acute myocarditis is commonly associated with viral infections, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). ...We present a case of acute myocarditis reported afte …
BACKGROUND: Acute myocarditis is commonly associated with viral infections, including severe acute respiratory
Safety and immunogenicity of synchronous COVID19 and influenza vaccination.
Baj A, Gasperina DD, Focosi D, Forlani G, Ferrante FD, Novazzi F, Azzi L, Maggi F. Baj A, et al. J Clin Virol Plus. 2022 Aug;2(3):100082. doi: 10.1016/j.jcvp.2022.100082. Epub 2022 May 7. J Clin Virol Plus. 2022. PMID: 35571072 Free PMC article.
Given the ongoing COVID19 pandemic, the decline in serological response since dose 2, and the upcoming flu season, COVID19 vaccines will increasingly be administered in combination with vaccines against seasonal pathogens. It is of interest to confirm that concurrent vacci …
Given the ongoing COVID19 pandemic, the decline in serological response since dose 2, and the upcoming flu season, COVID19 vaccines w …
COVID-19 Vaccine Intentions and Perceptions Among Public School Staff of the Greater Vancouver Metropolitan Area, British Columbia, Canada.
Watts AW, Hutchison SM, Bettinger JA, Gadermann A, Oberle E, Oberlander TF, Goldfarb DM, Lavoie PM, Mâsse LC. Watts AW, et al. Front Public Health. 2022 Apr 27;10:832444. doi: 10.3389/fpubh.2022.832444. eCollection 2022. Front Public Health. 2022. PMID: 35570951 Free PMC article.
METHODS: Staff (e.g., teachers, administrators, student support workers) from three urban school districts in the Greater Vancouver Area of British Columbia, Canada completed a survey between February and June 2021 (n = 2,393) on COVID-19 vaccine intentions a …
METHODS: Staff (e.g., teachers, administrators, student support workers) from three urban school districts in the Greater Vancouver Area of …
Parents' Hesitancy to Vaccinate Their Children Against COVID-19, a Country-Wide Survey.
Alhazza SF, Altalhi AM, Alamri KM, Alenazi SS, Alqarni BA, Almohaya AM. Alhazza SF, et al. Front Public Health. 2022 Apr 28;10:755073. doi: 10.3389/fpubh.2022.755073. eCollection 2022. Front Public Health. 2022. PMID: 35570948 Free PMC article.
OBJECTIVE: Parents' hesitancy (PH) toward childhood vaccination, including the vaccine of coronavirus disease (COVID-19), is one of the top public health threats. ...More than half of the parents were positive toward the childhood COVID-19
OBJECTIVE: Parents' hesitancy (PH) toward childhood vaccination, including the vaccine of coronavirus disease (COVID- …
Analyzing Russian Media Policy on Promoting Vaccination and Other COVID-19 Risk Mitigation Measures.
Stepanov I, Komendantova N. Stepanov I, et al. Front Public Health. 2022 Apr 29;10:839386. doi: 10.3389/fpubh.2022.839386. eCollection 2022. Front Public Health. 2022. PMID: 35570928 Free PMC article.
The coronavirus disease 2019 (COVID-19) pandemic has resulted in many tangible and intangible losses. ...In addition, social media grew in importance because of the spread of technologies and as a result of the increased attention to information …
The coronavirus disease 2019 (COVID-19) pandemic has resulted in many tangible and intangible losses. ... …
COVID-19 Vaccine Hesitancy in Italy: Predictors of Acceptance, Fence Sitting and Refusal of the COVID-19 Vaccination.
Zarbo C, Candini V, Ferrari C, d'Addazio M, Calamandrei G, Starace F, Caserotti M, Gavaruzzi T, Lotto L, Tasso A, Zamparini M, de Girolamo G. Zarbo C, et al. Front Public Health. 2022 Apr 29;10:873098. doi: 10.3389/fpubh.2022.873098. eCollection 2022. Front Public Health. 2022. PMID: 35570888 Free PMC article.
BACKGROUND: The hesitancy in taking the COVID-19 vaccine is a global challenge. The need to identify predictors of COVID-19 vaccine reluctance is critical. ...CONCLUSIONS: The "fence sitters" profile revealed by this study is intriguing and should be t …
BACKGROUND: The hesitancy in taking the COVID-19 vaccine is a global challenge. The need to identify predictors of COVID
Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Mancarella M, Natarelli F, Bertolini C, Zagari A, Enrica Bettinelli M, Castaldi S. Mancarella M, et al. Vaccine. 2022 May 12:S0264-410X(22)00573-4. doi: 10.1016/j.vaccine.2022.05.005. Online ahead of print. Vaccine. 2022. PMID: 35570078 Free PMC article.
BACKGROUND: COVID-19 has led to disruption in routine immunization programs around the world. Effective strategies need to be developed to address the decline in vaccine coverage to avoid preventable disease outbreaks. Our study reports a 4-days campaign for …
BACKGROUND: COVID-19 has led to disruption in routine immunization programs around the world. Effective strategies need to be …
Impact of national Covid-19 vaccination Campaign, South Korea.
Yi S, Choe YJ, Lim DS, Lee HR, Kim J, Kim YY, Kim RK, Jang EJ, Lee S, Park E, Kim SJ, Park YJ. Yi S, et al. Vaccine. 2022 May 8:S0264-410X(22)00572-2. doi: 10.1016/j.vaccine.2022.05.002. Online ahead of print. Vaccine. 2022. PMID: 35570077 Free PMC article.
METHODS: The National Surveillance System with the National Immunization Registry were linked to form a large-linked database for assessment. Age-adjusted incidence of SARS-CoV-2 infection, severe disease, and death by vaccination status are cal …
METHODS: The National Surveillance System with the National Immunization Registry were linked to form a large-linked database for assessment …
Delayed Vasovagal Reaction with Reflex Syncope Following Covid-19 Vaccination.
Takase B, Hayashi K, Takei S, Hisada T, Masaki N, Nagata M. Takase B, et al. Intern Med. 2022 May 14. doi: 10.2169/internalmedicine.9318-21. Online ahead of print. Intern Med. 2022. PMID: 35569982
Coronavirus disease 2019 (COVID-19) has become a pandemic, and vaccines remain the only effective tools available for ending it. ...We herein report 6 cases of delayed vasovagal syncope and presyncope (VVR) caused by COVID-19 vacci
Coronavirus disease 2019 (COVID-19) has become a pandemic, and vaccines remain the only effective tools a
Graves' Disease after Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in a Type 1 Diabetes Patient.
Sakai M, Takao K, Kato T, Ito K, Kubota S, Hirose T, Liu Y, Mizuno M, Hirota T, Suwa T, Horikawa Y, Yabe D. Sakai M, et al. Intern Med. 2022;61(10):1561-1565. doi: 10.2169/internalmedicine.9231-21. Epub 2022 May 15. Intern Med. 2022. PMID: 35569928
Although there is a great demand for increased coronavirus disease 2019 (COVID-19) vaccination worldwide, rare side effects of the vaccine in susceptible individuals are attracting attention. We recently treated a patient with type 1 diabetes wh …
Although there is a great demand for increased coronavirus disease 2019 (COVID-19) vaccination worldwide, …
Pemphigus Vulgaris after COVID-19 Infection and Vaccination.
Zou H, Daveluy S. Zou H, et al. J Am Acad Dermatol. 2022 May 12:S0190-9622(22)00803-9. doi: 10.1016/j.jaad.2022.05.013. Online ahead of print. J Am Acad Dermatol. 2022. PMID: 35569594 No abstract available.
Proposing a Standardized Assessment of COVID-19 Vaccine Cutaneous Reactions.
Singh R, Ali R, Prasad S, Chen ST, Blumenthal K, Freeman EE. Singh R, et al. J Am Acad Dermatol. 2022 May 12:S0190-9622(22)00801-5. doi: 10.1016/j.jaad.2022.05.011. Online ahead of print. J Am Acad Dermatol. 2022. PMID: 35569593 Free PMC article. No abstract available.
New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan.
Nakagawa N, Maruyama S, Kashihara N, Narita I, Isaka Y. Nakagawa N, et al. Clin Exp Nephrol. 2022 May 15:1-8. doi: 10.1007/s10157-022-02231-y. Online ahead of print. Clin Exp Nephrol. 2022. PMID: 35569069 Free PMC article.
BACKGROUND: Recent clinical reports indicate a correlation between new-onset and relapse of nephrotic syndrome (NS) following coronavirus 2019 (COVID-19) vaccination in patients with glomerular diseases. ...RESULTS: Following COVID
BACKGROUND: Recent clinical reports indicate a correlation between new-onset and relapse of nephrotic syndrome (NS) following …
Vaccines and the social amplification of risk.
Larson HJ, Lin L, Goble R. Larson HJ, et al. Risk Anal. 2022 May 14. doi: 10.1111/risa.13942. Online ahead of print. Risk Anal. 2022. PMID: 35568963
Shortly afterward, the COVID-19 pandemic emerged as the world's predominant health concern. ...The previous waves of vaccine hesitancy that led to the WHO threat designation, together with recent COVID-19 experience, provide a window for viewing new
Shortly afterward, the COVID-19 pandemic emerged as the world's predominant health concern. ...The previous waves of vaccine h …
Covid-19 in children aged 5-11: Examining the issues surrounding vaccination and public health policy.
Myers V, Saban M, Wilf-Miron R. Myers V, et al. Paediatr Respir Rev. 2022 Apr 21:S1526-0542(22)00031-8. doi: 10.1016/j.prrv.2022.03.002. Online ahead of print. Paediatr Respir Rev. 2022. PMID: 35568661 Free PMC article. Review.
METHODS: Data were obtained from Israel's open COVID database regarding new confirmed daily COVID-19 cases, severe hospitalized cases and deaths by age group in Israel from February 2020-November 2021, as well as vaccination rate and adverse eve …
METHODS: Data were obtained from Israel's open COVID database regarding new confirmed daily COVID-19 cases, s
Covid-19 vaccine immunogenicity in people living with HIV-1.
Nault L, Marchitto L, Goyette G, Tremblay-Sher D, Fortin C, Martel-Laferrière V, Trottier B, Richard J, Durand M, Kaufmann D, Finzi A, Tremblay C. Nault L, et al. Vaccine. 2022 May 5:S0264-410X(22)00543-6. doi: 10.1016/j.vaccine.2022.04.090. Online ahead of print. Vaccine. 2022. PMID: 35568588 Free PMC article.
INTRODUCTION: COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. ...A control group of 20 health care workers naive to SARS CoV-2 was used. The participants' Anti-RBD IgG responses were measured by …
INTRODUCTION: COVID-19 vaccine efficacy has been evaluated in large clinical trials and in real-world situation. ...A control …
16,427 results
You have reached the last available page of results. Please see the User Guide for more information.